Inovio Pharmaceuticals, Inc.INONASDAQ
LOADING
|||
EBITDA Over Time
Trending higher, above historical average, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-103.95M
↑ 22% above average
Average (9y)
$-134.08M
Historical baseline
Range
High:$-33.37M
Low:$-296.56M
CAGR
+13.5%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-103.95M | +20.3% |
| 2023 | $-130.39M | +51.9% |
| 2022 | $-270.90M | +8.7% |
| 2021 | $-296.56M | -98.3% |
| 2020 | $-149.56M | -39.3% |
| 2019 | $-107.34M | -19.5% |
| 2018 | $-89.80M | -6.0% |
| 2017 | $-84.74M | -14.3% |
| 2016 | $-74.15M | -122.2% |
| 2015 | $-33.37M | - |